India, US Discuss Trade & Investment Boost at TPF Meet

By By Rediff Money Desk, NEWDELHI
Jan 12, 2024 20:43
India and the US discussed ways to enhance trade and investment ties during the 14th Trade Policy Forum (TPF) meeting in New Delhi, focusing on key issues like social security pact, market access for Indian products, and USFDA inspections.
New Delhi, Jan 12 (PTI) India and the US on Friday discussed ways to further boost trade and investment ties between the two countries during the Trade Policy Forum (TPF) meet here.

The 14th TPF meet was co-chaired by Commerce and Industry Minister Piyush Goyal and United States Trade Representative (USTR) Katherine Tai.

"Amidst productive deliberations, both sides reiterated their commitment to enhance trade and investment ties for adding further momentum to the growing India-US partnership," Goyal said in a post on social media platform X.

Officials had on Thursday said India would raise a number of issues with the US, such as inking social security pact, and greater market access for products like mangoes and pharma in America during the TPF meet.

India has also planned to raise issues pertaining to delay in visa; increasing exports of table grapes, pharma goods, and marine products like wild caught fish and shrimp; reinstating the Generalized System of Preferences (GSP) status to India; and export control regulations for high-tech products and technologies.

Social security, or totalisation agreement, is a long-pending demand of the country, as it will provide social security to Indian professionals in America. This would eliminate dual social security deduction, both in the home country and in the nation where an employee works.

Under this, an expatriate in either country need not contribute to the social security scheme of the host country.

It will benefit a number of Indians, particularly from the IT sector, who are working in America and paying social security but are unable to get any benefit out of it.

India is also seeking fast-tracking American health regulator's USFDA inspections, or audit of domestic pharma firms.

United States Food and Drug Administration (USFDA) approval is required to sell medicines in the US market. Before giving the approval, the USFDA authorities visit premises of manufacturing units for checking quality standards.

The last TPF meeting was held in Washington in January 2023.

TPF is a platform to resolve trade and investment issues between the two countries. It has five focus groups -- agriculture, investment, innovation, and creativity (intellectual property rights), services, and tariff and non-tariff barriers.

The US is the largest trading partner of India. America accounts for about 20 per cent of India's total exports in goods and is a key market for services sectors like IT.

The bilateral trade between the countries has increased to USD 129.4 billion in 2022-23 from USD 120 billion in 2021-22. India received USD 6 billion in foreign direct investment from the US in 2022-23.
Read More On:
indiaustradeinvestmenttpftrade policy forumpiyush goyalkatherine taisocial securitymarket accessmangoespharmausfdainspectionsbilateral trade
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com